Related Experiment Videos
The current state of infectious disease: a clinical perspective on antimicrobial resistance
1National Cancer Institute, National Institutes of Health, Bethesda, Maryland, MD 20892, USA.
Abstract:
The medical community is in the midst of a wake-up call. No longer can antimicrobial use be taken for granted. The overprescribing of antimicrobials has taken its toll and the consequence has been a precipitous increase in drug-resistant pathogens seen over the last decade. Pharmaceutical companies and researchers are no longer able to keep a step ahead of these resistant pathogens with new antimicrobial agents. The primary care clinician is now faced with complicated treatment issues for many infectious diseases that were once considered uncomplicated. The mechanisms leading to the development of antimicrobial resistance in bacteria is discussed in addition to an overview of the most common drug-resistant pathogens.
Insights
Antimicrobial resistance is rising due to overuse, creating difficult-to-treat infections. New drugs struggle to keep pace with evolving drug-resistant pathogens, challenging clinicians.
Area of Science:
- Medical microbiology
- Infectious diseases
- Antimicrobial stewardship
Background:
- The medical community faces a critical challenge with rising antimicrobial resistance.
- Overprescribing of antimicrobials has led to a significant increase in drug-resistant pathogens.
- Developing new antimicrobial agents struggles to outpace the evolution of resistant strains.
Purpose of the Study:
- To discuss the mechanisms driving antimicrobial resistance in bacteria.
- To provide an overview of prevalent drug-resistant pathogens.
- To highlight the challenges faced by primary care clinicians in treating resistant infections.
Main Methods:
- Literature review on antimicrobial resistance mechanisms.
- Analysis of trends in drug-resistant pathogen emergence.
- Clinical case study review (implied).
Main Results:
- Antimicrobial resistance is a growing global health concern.
- Common drug-resistant pathogens pose significant treatment challenges.
- Existing antimicrobial therapies are becoming less effective.
Conclusions:
- Urgent need for antimicrobial stewardship to curb resistance.
- Primary care clinicians require updated strategies for managing resistant infections.
- Continued research into novel antimicrobial agents and alternative therapies is essential.